Stem Cell Research & Therapy · 2021 · 117 citations · 21 references
Life SciencesCell BiologyImmunologyCell SignalingInflammationStem Cell BiologyAcute Liver FailureInflammasome ActivationLiver DiseaseMacrophage BiologyMesenchymal Stem Cell TherapyMesenchymal Stromal Cell TherapyAcute Liver Failure TreatmentCell Death DetectionHepatic Inflammatory InjuryHepatocyte Cell Death MechanismsInflammatory Liver InjuryLiver Cell Death PathwaysMacrophage Inflammasome ActivationNlrp3 Inflammasome
Abstract Background Acute liver failure (ALF) is an acute inflammatory liver disease with high mortality. Previous preclinical and clinical trials have confirmed that mesenchymal stem cell (MSC) is a promising therapeutic approach; however, the effect is not satisfied as the underlying molecular mechanisms of MSC in treating ALF remain unclear. Methods MSC isolated from 4- to 6-week-old C57BL/6 mice were used to treat ALF. Histological and serological parameters were analyzed to evaluate the efficacy of MSC. We explored the molecular mechanism of MSC in the treatment of ALF by detecting liver inflammatory response and hepatocyte death. Results In this study, we found that the therapeutic potential of MSC on ALF is dependent on the secretion of prostaglandin E 2 (PGE 2 ), a bioactive lipid. MSC-derived PGE 2 inhibited TGF-β-activated kinase 1 (TAK1) signaling and NLRP3 inflammasome activation in liver macrophages to decrease the production of inflammatory cytokines. Meanwhile, macrophages in the liver could be induced to anti-inflammatory (M2) macrophages by MSC-derived PGE 2 via STAT6 and mechanistic target of rapamycin (mTOR) signaling, which then promote inflammatory resolution and limit liver injury. Finally, administrating EP4 antagonist significantly ameliorated the therapeutic ability of MSC, which promoted liver inflammation and decreased M2 macrophages. Conclusions Our results indicate that PGE 2 might be a novel important mediator of MSC in treating ALF, which is through inhibiting the liver inflammatory response and hepatocyte death.
21
EASL Clinical Practice Guidelines: Liver transplantation
Journal of Hepatology · 2015 · 1.1K citations
Medicine, Internal Medicine, Surgery +14
The TSC-mTOR pathway regulates macrophage polarization
Vanessa Byles, Anthony J. Covarrubias, Issam Ben‐Sahra et al. · Nature Communications · 2013 · 627 citations · Full text